The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2A trial of synthetic DNA vaccine immunotherapy targeting HPV-16 and -18 after chemoradiation for cervical cancer.
 
Yasmin Hasan
Research Funding - Inovio Pharmaceuticals (Inst)
 
Michael T. Spiotto
No Relationships to Disclose
 
Larissa V Furtado
No Relationships to Disclose
 
Ana Isabel Tergas
No Relationships to Disclose
 
Nita Karnik Lee
No Relationships to Disclose
 
Rebecca A. Brooks
No Relationships to Disclose
 
Anne Ritke McCall
No Relationships to Disclose
 
Daniel William Golden
Stock and Other Ownership Interests - HemOnc.org; RadOnc Questions
 
Shruti Jolly
Honoraria - Varian Medical Systems
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
 
Matthew P Morrow
Employment - Inovio Pharmaceuticals
Stock and Other Ownership Interests - Inovio Pharmaceuticals
 
Jeffrey Skolnik
Employment - Inovio Pharmaceuticals; TetraLogic Pharmaceuticals
Stock and Other Ownership Interests - Inovio Pharmaceuticals; TetraLogic Pharmaceuticals
Research Funding - Inovio Pharmaceuticals; TetraLogic Pharmaceuticals
 
Mark Esser
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
Travel, Accommodations, Expenses - MedImmune
 
Rakesh Kumar
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Ralph R. Weichselbaum
Stock and Other Ownership Interests - Immune Cell Therapy
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca; Merck KGaA
Research Funding - Regeneron; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Tvec
Travel, Accommodations, Expenses - AstraZeneca; Immune Cell Therapy